awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36725445-BB4FA812-AFF8-4AA2-A473-0BAA8B0C273F
Q36725445-BB4FA812-AFF8-4AA2-A473-0BAA8B0C273F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36725445-BB4FA812-AFF8-4AA2-A473-0BAA8B0C273F
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).
P2860
Q36725445-BB4FA812-AFF8-4AA2-A473-0BAA8B0C273F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36725445-BB4FA812-AFF8-4AA2-A473-0BAA8B0C273F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f742c970159114142ea69da82d5ca552eb124c98
P2860
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.